Xcel Brands (XELB) Q3 2024 earnings summary

Executive summary

• Transitioned to a working capital-light licensing model after discontinuing all wholesale operations and divesting the Lori Goldstein Brand, resulting in lower product sales and revenue.

• Licensing revenues remained stable overall, with growth in brands like C. Wonder and Tower Hill by Christie Brinkley, but declines in Lori Goldstein and Qurate agreements.

• Adjusted EBITDA improved by nearly 50% year-over-year in early 2024 and continued to improve in Q3, reflecting cost reductions and operational focus.

• Major restructuring reduced annualized direct operating expenses to $11M and eliminated significant contingent obligations.

• New brand launches and partnerships, including Halston by G-III and Tower Hill by Christie Brinkley, are expected to drive future growth.

Financial highlights

• Q1 2024 total revenue was $2.2M, Q3 2024 net revenue was $1.91M, both down year-over-year due to the exit from wholesale and divestitures.

• Licensing revenue held steady at $2.2M in Q1, but declined to $1.51M in Q3; net product sales were $0.41M in Q3.

• Direct operating costs fell 43% to $4M in Q1; annualized direct operating expenses now at $11M.

• GAAP net loss was $6.3M in Q1 and $9.21M in Q3, with non-cash charges related to asset impairments and contingent obligations.

• Adjusted EBITDA was negative $1.6M in Q1 and negative $1.05M in Q3, both showing improvement year-over-year.

Outlook and guidance

• Expectation to return to profitability in 2024, with positive EBITDA anticipated later in the year.

• Revenue and EBITDA growth projected to accelerate in Q3 and Q4 as new licenses ramp up.

• Management expects existing cash, future operating cash flows, and the new $10M term loan to be sufficient for at least 12 months post-filing.

• Direct operating expenses are expected to remain at a run rate of $11M per annum following restructuring.

• C. Wonder by Christian Siriano projected to reach $20–25M in retail sales in 2024, with a goal of $50M in 2025.